Literature DB >> 28353287

Mechanisms of Mutant LRRK2 Neurodegeneration.

Mark R Cookson1.   

Abstract

LRRK2 mutations are associated with the loss of neurons, that is to say toxicity, in patients and in experimental model systems. However, the mechanisms by which mutations can be linked to neurodegeneration are not fully defined. Here I will argue that mechanism in this context encompasses a variety of levels of information. Mutations or alterations in gene expression at a genetic level are one set of mechanisms that are reflected at the biochemical level likely in enhanced or persistent function of LRRK2. By impacting cellular pathways, prominently including changes in autophagy but also microtubule function, mitochondria and protein synthesis, in neurons and immune cells, the LRRK2 brain is primed for neurodegeneration in an age-dependent manner. These concepts have implications for not only modeling LRRK2 disease but also perhaps for Parkinson's disease more generally, including the development of therapeutic modalities.

Entities:  

Keywords:  GTPase; Gene expression; Kinase; Mutations; Pleomorphic risk locus; Rab7L1; α-Synuclein

Mesh:

Substances:

Year:  2017        PMID: 28353287     DOI: 10.1007/978-3-319-49969-7_12

Source DB:  PubMed          Journal:  Adv Neurobiol


  20 in total

Review 1.  LRRK2 in Parkinson disease: challenges of clinical trials.

Authors:  Eduardo Tolosa; Miquel Vila; Christine Klein; Olivier Rascol
Journal:  Nat Rev Neurol       Date:  2020-01-24       Impact factor: 42.937

Review 2.  Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.

Authors:  Yasir H Qureshi; Penelope Baez; Christiane Reitz
Journal:  Mol Cell Biol       Date:  2020-09-14       Impact factor: 4.272

3.  The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2.

Authors:  Xiaorong Huang; Chunxiang Wu; Yangshin Park; Xuwei Long; Quyen Q Hoang; Jingling Liao
Journal:  FASEB J       Date:  2018-12-28       Impact factor: 5.191

4.  Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils.

Authors:  Ying Fan; Andrew J M Howden; Adil R Sarhan; Pawel Lis; Genta Ito; Terina N Martinez; Kathrin Brockmann; Thomas Gasser; Dario R Alessi; Esther M Sammler
Journal:  Biochem J       Date:  2018-01-02       Impact factor: 3.857

5.  Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase.

Authors:  Pawel Lis; Sophie Burel; Martin Steger; Matthias Mann; Fiona Brown; Federico Diez; Francesca Tonelli; Janice L Holton; Philip Winglok Ho; Shu-Leong Ho; Meng-Yun Chou; Nicole K Polinski; Terina N Martinez; Paul Davies; Dario R Alessi
Journal:  Biochem J       Date:  2018-01-02       Impact factor: 3.857

6.  Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.

Authors:  Angelique di Domenico; Giulia Carola; Carles Calatayud; Meritxell Pons-Espinal; Juan Pablo Muñoz; Yvonne Richaud-Patin; Irene Fernandez-Carasa; Marta Gut; Armida Faella; Janani Parameswaran; Jordi Soriano; Isidro Ferrer; Eduardo Tolosa; Antonio Zorzano; Ana Maria Cuervo; Angel Raya; Antonella Consiglio
Journal:  Stem Cell Reports       Date:  2019-01-10       Impact factor: 7.765

7.  Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons.

Authors:  Hyejung Kim; Hyuna Sim; Joo-Eun Lee; Mi Kyoung Seo; Juhee Lim; Yeojin Bang; Daleum Nam; Seo-Young Lee; Sun-Ku Chung; Hyun Jin Choi; Sung Woo Park; Ilhong Son; Janghwan Kim; Wongi Seol
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

8.  Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.

Authors:  Linn Streubel-Gallasch; Veronica Giusti; Michele Sandre; Isabella Tessari; Nicoletta Plotegher; Elena Giusto; Anna Masato; Ludovica Iovino; Ilaria Battisti; Giorgio Arrigoni; Derya Shimshek; Elisa Greggio; Marie-Eve Tremblay; Luigi Bubacco; Anna Erlandsson; Laura Civiero
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

9.  RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A.

Authors:  Jesús Madero-Pérez; Belén Fernández; Antonio Jesús Lara Ordóñez; Elena Fdez; Evy Lobbestael; Veerle Baekelandt; Sabine Hilfiker
Journal:  Front Mol Neurosci       Date:  2018-11-13       Impact factor: 5.639

10.  Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients.

Authors:  Belén Fernández; Antonio Jesús Lara Ordóñez; Elena Fdez; Eugénie Mutez; Thomas Comptdaer; Coline Leghay; Alexandre Kreisler; Clémence Simonin; Laurine Vandewynckel; Luc Defebvre; Alain Destée; Séverine Bleuse; Jean-Marc Taymans; Marie-Christine Chartier-Harlin; Sabine Hilfiker
Journal:  Biochem J       Date:  2019-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.